INmune Bio Inc.
Symbol:
NASDAQ: INMB
Market Cap:
Private
Sector:
Biotechnology
Summary:
- A novel strategy that treats Alzheimer’s disease as an immunologic, not neurologic disease.
- Our goal is to remodel, repair and restore the aging brain to prevent cognitive decline, not to slow cognitive decline.
- In Phase II clinical trials with top line data in 12 months